三(o-溴苄基)锡吡咯烷基二硫代甲酸酯的合成、结构及体外抗癌活性

利用三(o-溴苄基)溴化锡与吡咯烷基二硫代甲酸钠反应,合成了三(o-溴苄基)锡吡咯烷基二硫代甲酸酯。用X射线单晶衍射测定了其晶体结构,化合物为三斜晶系,空间群P1,晶体学参数a=0.91354(11)nm,b=1.07313(13)nm,c=1.52677(18)nm,α=75.440(6)°,β=89.499(6)°,γ=72.515(7)°,V=1.3781(3)nm3,Z=2,Dc=1.868 g/cm3,μ(MoKα)=54.43 cm-1,F(000)=752,R1=0.0320,wR2=0.0765。化合物中的锡原子为四配位畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了配合物体外抗癌活性。     

二(o-溴苄基)锡双(二乙基二硫代氨基甲酸)酯和二(o-氯苄基)锡双(吡咯啶二硫代氨基甲酸)酯的合成、结构及体外抗癌活性研究

二（o-溴苄基）二溴化锡和二（o-氯苄基）二氯化锡分别与N,N-二乙基二硫代氨基甲酸钠和吡咯啶二硫代氨基甲酸钠反应,合成了二（o-溴苄基）锡双（二乙基二硫代氨基甲酸）酯（1）和二（o-氯苄基）锡双（吡咯啶二硫代氨基甲酸）酯（2）。用X-射线单晶衍射测定了两个化合物的晶体结构,测试结果表明：化合物1的晶体为单斜晶系,空间群P2₁/c,晶体学参数a=1.82736（4）nm,b=0.90060（2）nm,c=1.98841（5）nm,β=114.8780（10）°,V=2.96871（12）nm³,Z=4,D_c=1.690g·cm^-3,μ（MoKα）=38.50cm^-1,F（000）=1496,R₁=0.0516,wR₂=0.1546。化合物2的晶体为单斜晶系,空间群C2/c,晶体学参数a=2.24128（4）nm,b=0.81878（2）nm,c=1.54269（3）nm,β=106.7870（10）°,V=2.71037（10）nm³,Z=4,D_c=1.623g·cm^-3,μ（MoKα）=14.65cm^-1,F（000）=1336,R₁=0.0229,wR₂=0.0565。晶体中锡原子呈六配位畸变八面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了配合物的热稳定性和体外抗癌活性。     

三(3,5-二甲基苄基)氯化锡和四(间氰基苄基)锡的合成、晶体结构和量子化学研究

以3,5-二甲基苄基氯和间氰基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二甲基苄基)氯化锡(1)和四(间氰基苄基)锡(2),经X射线衍射方法测定了化合物的晶体结构。化合物1属单斜晶系,空间群为P21/m,晶体学参数:a=0.584 03(4)nm,b=1.966 37(14)nm,c=0.856 46(5)nm,β=95.138(3),V=0.979 62(11)nm3,Z=2,Dc=1.735 g·cm-3,μ(Mo Kα)=14.53 cm-1,F(000)=524,R1=0.043 7,w R2=0.123 2。化合物2属单斜晶系,空间群为C2/c,晶体学参数:a=1.692 21(12)nm,b=1.167 41(8)nm,c=1.539 41(11)nm,β=116.615(10)°,V=2.718 9(3)nm3,Z=4,Dc=1.424 g·cm-3,μ(Mo Kα)=9.67cm-1,F(000)=1 176,R1=0.017 5,w R2=0.046 1;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。     

三(3,5-二氟苄基)氯化锡和四(邻氯苄基)锡的合成、晶体结构及量子化学

3,5-二氟苄基氯和邻氯基苄基氯在适当的溶剂中与锡粉反应,合成了三(3,5-二氟苄基)氯化锡(1)和四(邻氯苄基)锡(2),经X射线衍射方法测定了新化合物的晶体结构。化合物1属单斜晶系,空间群为C2/c,晶体学参数:a=1.858 33(11)nm,b=1.140 98(7)nm,c=2.690 06(16)nm,β=109.288(10)°,V=5.383 6(6)nm3,Z=8,Dc=1.532 g·cm~(-3),μ(Mo Kα)=13.61 cm~(-1),F(000)=2 480,R1=0.085 1,wR~2=0.168 1。化合物2属单斜晶系,空间群为P21/m,晶体学参数:a=0.585 54(5)nm,b=1.969 74(18)nm,c=0.857 86(8)nm,β=95.204 0(10)°,V=0.985 34(15)nm3,Z=2,Dc=1.805 g·cm~(-3),μ(Mo Kα)=14.91 cm-1,F(000)=524,R1=0.054 0,wR_2=0.163 9;中心锡原子为畸变四面体构型。对其结构进行量子化学从头计算,探讨了化合物的稳定性、分子轨道能量以及部分前沿分子轨道的组成特征。测定了化合物的热稳定性。     

三(邻甲基苄基)锡和二(间氟苄基)锡硫代水杨酸酯配合物的合成、结构及性质

合成了三(邻甲基苄基)锡硫代水杨酸酯配合物(1)和一维链状二(间氟苄基)锡硫代水杨酸酯配合物(2),经元素分析、IR、NMR、X射线衍射等技术手段表征了其结构。配合物1属三斜晶系,空间群Pī,晶体学参数a=1.00221(5)nm,b=1.48934(8)nm,c=1.71789(9)nm,α=78.3120(10)°,β=85.6560(10)°,γ=80.2580(10)°,V=2.4725(2)nm~3,Z=2,Dc=1.371 g/cm~3,μ(Mo Kα)=10.91 cm~(-1),F(000)=1040,R_1=0.0439,wR_2=0.1119。配合物2属单斜晶系,空间群为P21/n,晶体学参数:a=1.17827(5)nm,b=2.11945(9)nm,c=1.55970(7)nm,β=93.4510(10)°,V=3.8880(3)nm~3,Z=4,Dc=1.671 g/cm~3,μ(Mo Kα)=14.53 cm~(-1),F(000)=1936,R1=0.0323,wR2=0.0927。配合物1中锡原子呈四配位畸变四面体构型,配合物2中锡原子呈五配位畸变三角双锥构型。配合物1和2分别在152和195℃下稳定,电化学性质不可逆,对人体癌细胞Colo205、Hep G2、MCF-7、Hela和NCI-H460具有体外抗癌活性,配合物2的抗癌活性远大于配合物1。     

三(邻溴苄基)溴化锡和四(对溴苄基)锡的合成及结构研究

邻溴苄基溴或对溴苄基溴与锡反应合成三(邻溴苄基)溴化锡(1)和四(对溴苄基)锡(2).经X射线方法测定了新化合物的晶体结构.晶体结构1属斜方六面体晶系,空间群为R-3,晶体学参数:a=1.3389(3) nm, b=1.3389(3) nm, c=2.1896(8) nm, V=3.3993(16) nm3, Z=6, Dx=2.077 Mg·m-3, μ(Mo Kα)=81.83 cm-1, F(000)=2004, R1=0.0477, wR2=0.1372;晶体结构2属正交晶系,空间群为Fdd2,晶体学参数:a=2.1027(7) nm, b=2.3034(8) nm, c=1.1431(4) nm, V=5. 536(3) nm3, Z=8, Dx=1.917 Mg·m-3, μ(Mo Kα)=67.11 cm-1, F(000)=3056, R1=0.0358, wR2=0.0659.化合物1中Sn-C键长为0.2160(8) nm, Sn-Br键长为0.2491(3) nm;化合物2中Sn-C键长分别为0.2175和0.2178 nm.中心锡与亚甲基碳(或溴)原子构成畸型四面体.     

微波固相合成三(邻氯苄基)锡肉桂酸酯及其结构与量子化学研究

三(邻氯苄基)氯化锡与肉桂酸按物质的量比1∶1,通过微波固相反应合成了三(邻氯苄基)锡肉桂酸酯。经X-射线衍射方法测定了其晶体结构,化合物属三斜晶系,空间群为P1,晶体学参数a=0.974 91(3)nm,b=1.096 57(3)nm,c=1.485 91(4)nm,α=104.115 0(10)°,β=90.241 0(10)°,γ=111.715 0(10)°,V=1.423 35(7)nm3,Z=2,Dc=1.499 g.cm-3,μ(Mo Kα)=12.04 cm-1,F(000)=644,R1=0.024 9,wR2=0.083 6。中心锡与亚甲基碳和羧基氧原子构成畸型四面体。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及一些前沿分子轨道的组成特征。     

三(对氟苄基)氯化锡和三(对氟苄基)锡N,N-(1,4-亚丁基)氨荒酸酯的合成及晶体结构

合成了三(对氟苄基)氯化锡(1)和三(对氟苄基)锡N,N-(1,4-亚丁基)氨荒酸酯(2).通过元素分析、红外光谱和核磁共振氢谱对其结构进行了表征.用X射线单晶衍射测定了这两个化合物的晶体结构.化合物1为单斜晶系,空间群P21, a=0.8403(3) nm, b=0.5958(2) nm, c=2.0016(8) nm, β=97.052(6)°, Z=2, V=0.9945(7) nm3, Dc=1.608 g/cm3, μ=1.447 mm-1, R1=0.0397, wR2=0.0813.化合物2为单斜晶系,空间群P21/n, a=0.8786(9) nm, b=1.993(2) nm, c=1.5039(15) nm, β=103.548(15)°, Z=4, V=2.560(4) nm3, Dc=1.537 g/cm3, μ=1.197 mm-1, R1=0.0363, wR2=0.0796. 在1的晶体中,锡原子呈四配位畸变四面体构型;2的晶体中,锡原子则是五配位畸变三角双锥构型.     

有机锡配合物{[(o-MeC6H4CH2)2Sn(O)]2(o-MeC6H4CH2NHO)}2的合成、结构和性质研究

二(o-甲基苄基)二氯化锡与N-(o-甲基苄基)羟胺在碱性条件下反应,合成了有机锡配合物{[(o-MeC6H4CH2)2Sn(O)]2(o-MeC6H4CH2NHO)}2。经X-射线衍射方法测定了化合物的晶体结构。该化合物晶体属三斜晶系,空间群P-1,晶体学参数 a =1.0604(5) nm,b =1.3078(7) nm,c = 1.3742(47 nm,α=105.174(12)?,β = 90.229(7)?,γ=101.028(6)?,Z = 1,V =1.8025(15) nm3,Dc=1.522Mg•m-3,?(MoKa)= 1.423 mm-1,F(000)= 834,R1=0.0455,wR2=0.1017。化合物是三个以Sn2O2构成的平面四元环组成的梯状结构,锡原子均为五配位的畸变三角双锥构型。测定了配合物的体外抗癌活性,结果表明配合物对WiDr和MCF-7等癌细胞有一定的抑制能力。     

二(对氯苄基)锡双吗啉氨荒酸酯和二(对氯苄基)氯化锡N,N-二乙基氨荒酸酯的合成、表征及晶体结构

利用二(对氯苄基)二氯化锡和吗啉氨荒酸钠、N,N-二乙基氨荒酸钠反应,合成了二(对氯苄基)锡双吗啉氨荒酸酯C24H28Cl2N2O2S4Sn (Mr = 694.31) 1和二(对氯苄基)氯化锡N,N-二乙基氨荒酸酯C19H22Cl3NS2Sn (Mr = 553.54) 2。用X-射线单晶衍射测定了这2个化合物的晶体结构,测试结果表明:化合物1的晶体为单斜晶系,空间群C2/c, a = 21.998(9), b = 6.469(3), c = 20.204(8) ,β= 94.444(6)o , Z = 4, V = 2866.3(19) 3, Dc = 1.609 g/cm3, μ(MoKα) = 1.394 mm-1, F(000) = 1400,S = 0.955, (?)max = 0.000,R = 0.0389, wR = 0.0817。化合物2的晶体为单斜晶系,空间群P21/c, a = 13.088(10), b = 9.304(7), c = 19.593(14) ,β = 107.158(10)o, Z = 4, V = 2280(3) 3, Dc = 1.613 g/cm3,μ(MoKα) = 1.660 mm-1, F(000) = 1104,S = 1.010, (?)max = 0.001,R = 0.0290, wR = 0.0651。在化合物1中,锡原子呈六配位畸变八面体构型, 化合物2的锡原子则是五配位畸变三角双锥构型。     

二(对-氯苄基)二氯化锡的合成及晶体结构

用 X射线方法测定了二 (对氯苄基 )二氯化锡的晶体结构,该化合物晶体属单斜晶系,空间群为 C2/c,晶体学参数： a=2.8010(3), b=0.4882(2), c=1.2174(3)nm,β =111.71(1)°, V=1.5467(7) nm3, Z=4, Dx=1.893g· cm－ 3,μ (MoKα )=23.24cm－ 1, F(000)=856.00, R=0.025, Rw=0.038, Sn C键长为 0.2148(3)nm, Sn Cl键长为 0.23754(9)nm。空间构型为畸变四面体构型的单分子有机锡化合物。     

Studies on the Synthesis,Crystal Structure and Quantum Chemistry of Di(o-cyanobenzyl)tin Bis(quinoline-2-carboxylate)

Di(o-cyanobenzyl)tin bis(quinoline-2-carboxylate)was synthesized by the reaction of tri(o-cyanobenzyl)tin chloride with quinoline-2-carboxylic acid.The molecular structure of the compound Was characterized by elemental analysis,IR,1H NMR and X-ray diffraction.Crystal data for the compound:triclinic,space group P1,a=0.80734(7),b=1.00681(9),c=1.04811(9)nm,α=81.7570(10),β=7.7240(10),γ=81.2850(10)°,V=0.77581(12)nm3,Z=1,Dc=1.488 g/cm3,μ(MoKa)=0.870 mm-1 and F(000)=350.1 The final R=0.0204 and wR=0.0530 for 2677 observed reflections with I＞2σ(I),and R=0.0208 and wR=0.0532 for all reflections.The molecular structure adopts a distorted octahedral geometry around the Sn atom.The title compound molecules are connected via hydrogen bonding interactions to form a 3D network structure.Quantum chemistry calculation study on the title compound has been performed by means of G98W package at the Lanl2dz basis set.The stability of the compound,orbital energies and some frontier molecular orbital composition characteristics have also been investigated.     

Studies on the Synthesis,Crystal Structure and Quantum Chemistry of Di（o-cyanobenzyl）tin Bis（quinoline-2-carboxylate）

Di（o-cyanobenzyl）tin bis（quinoline-2-carboxylate） was synthesized by the reaction of tri（o-cyanobenzyl）tin chloride with quinoline-2-carboxylic acid. The molecular structure of the compound was characterized by elemental analysis, IR, 1H NMR and X-ray diffraction. Crystal data for the compound： tficlinic, space group P1, a = 0.80734（7）, b = 1.00681（9）, c = 1.04811（9） nm, a = 81.7570（10）, β = 7.7240（10）,γ = 81.2850（10）°, V = 0.77581（12） nm3, Z = 1, Dc = 1.488 g/cm3, μ（MoKa） = 0.870 mm^-1 and F（000） = 350. The final R= 0.0204 and wR= 0.0530 for 2677 observed reflections with I 〉2σ（I）, and R = 0.0208 and wR = 0.0532 for all reflections. The molecular structure adopts a distorted octahedral geometry around the Sn atom. The title compound molecules are connected via hydrogen bonding interactions to form a 3D network structure. Quantum chemistry calculation study on the title compound has been performed by means of G98W package at the Lanl2dz basis set. The stability of the compound, orbital energies and some frontier molecular orbital composition characteristics have also been investigated.     

二(2-喹啉甲酸)二(邻氟苄基)锡配合物的合成、结构和量子化学研究

The novel di(o-fluorobenzyl)tin bis(2-quininate) has been synthesized. The crystal structures of the complex was determined by X-ray diffraction. The crystal belongs to triclinic space group P1 with a=0.770 8(2) nm, b=0.951 9(3) nm, c=1.108 4(3) nm, α=78.260(5)°, β=70.179(4)°, γ=68.594(4)°, V=0.709 4(4) nm³, Z=1, D_c=1.595 g·cm^-3, μ(Mo Kα)=9.57 cm^-1, F(000)=342, R₁=0.021 7, wR=0.056 6. The bond length Sn-C is 0.216 9(2) nm,The Sn-O is 0.217 64(15) nm, The Sn-N is 0.233 89(16) nm.This compound is monomeric, with six-coordinated tin atom in a distorted octahedron geometry. The study on title complex has been performed, with quantum chemistry calculation by means of G98W package and taking Lanl2dz basis set. The stabilities of the complex, the orbital energies and characteristics of some frontier molecular orbitals have been investigated. CCDC: 286107.     

梯形结构二(对甲基苄基)锡氧(氯)簇合物的合成、结构及量子化学研究

二(对甲基苄基)二氯化锡和氢氧化钠溶液反应,合成了梯形结构二(对甲基苄基)锡氧(氯)簇合物,经X-射线衍射测定了其晶体结构。属三斜晶系,空间群为P1,晶体学参数a=0.979 52(16) nm,b=1.313 8(2) nm,c=1.419 5(2) nm,α=62.965(10)°,β=88.551(12)°,γ=73.709(11)°,V=1.550 5(5) nm³,Z=1,D_c=1.563 g·cm^-3,μ(Mo Kα)=17.38 cm^-1,F(000)=727,R=0.024 2,wR=0.057 9。簇合物为由Sn₂O₂构成的平面四元环形成的1个中心内环和2个由Sn₂OCl(O)构成的平面四元外环组成的梯形结构。锡原子均为五配位三角双锥构型。对其结构进行量子化学从头计算,探讨了配合物的稳定性、分子轨道能量以及一些前沿分子轨道的组成特征。     

三(邻甲基苄基)氯化锡和二(对甲基苄基)二氯化锡的合成和晶体结构

将邻甲基氯苄和对甲基氯苄在适当的溶剂中与锡粉反应，合成了三(邻甲基苄基)氯化锡1和二(对甲基苄基)二氯化锡2，用X射线衍射方法测定了化合物的晶体结构。化合物(1)的晶体属三方晶系，空间群为R3，晶体学参数：a=1.329 36(8) nm，b=1.329 36(8) nm，c=2.147 0(3) nm，α=β=90°，γ=120°，V=3.285 8(5) nm³，Z=6，D_c=1.424 g·cm^-3，μ(Mo Kα)=12.93 cm^-1，F(000)=1 428，R₁=0.037 1，wR=0.110 2。化合物2的晶体属单斜晶系，空间群为C2/c，晶体学参数：a=2.850 4(3) nm，b=0.491 23(5) nm，c=1.215 32(12) nm，β=112.517(2)°，V=1.571 9(3) nm³，Z=4，D_c=1.690 g·cm^-3，μ(Mo Kα)=19.49 cm^-1，F(000)=792，R₁=0.038 0，wR₂=0.109 4；中心锡原子为畸变四面体配位构型。     

Bis(chlorido)tin(IV)meso-substituted Porphyrins-Characterization and Solubility

Investigation of the solubility behavior of para-substituted (H, Me, t-Bu, n-Bu) meso-tetraarylporphyrins as well as meso-tetraalkylporphyrins (Me, n-Pr, n-Bu) were performed. An increase of solubility in chloroform and benzene is detected according to the higher functionality in para position of the phenyl ring for meso-tetraarylporphyrins or in meso position on meso-tetraalkylporphyrins. Furthermore, the series of bis(chlorido)tin(IV) meso-tetraarylporphyrin and bis(chlorido)tin(IV) meso-tetraalkylporphyrin was investigated via UV/Vis spectroscopy, ¹¹⁹Sn-NMR and single crystal X-ray diffraction.     

二(o-氟苄基)锡双(四氢吡咯二硫代氨基甲酸酯)和二(p-氯苄基)锡双(二甲基二硫代氨基甲酸酯)的合成、表征及晶体结构

Di(o-fluorbenzyl)tin bis(dithiotetrahydropyrrolcarbamate) (1) and di(p-chlorbenzyl)tin bis(dithiomethylcarbamate) (2) were synthesized. Their structure were characterized by elementary analysis, IR and ¹H NMR and the crystal structure were determined by X-ray single crystal diffraction. The crystal of complex 1 belongs to orthorhombic with space group Pccn, a=2.096 1(12) nm, b=1.018 5(6) nm, c=1.205 9(7) nm, Z=4, V=2.574(2) nm³, D_c=1.624 g·cm^-3, μ(MoKα)=1.348 mm^-1, F(000)=1 272，R₁=0.038 7, wR₂=0.088 5. The crystal of complex 2 belongs to monoclinic with space group C2/c, a=1.531 3(16), b=1.868 4(19), c=0.951 8(10) nm, β=112.602(14)°, Z=4, V=2.514(5) nm³, D_c=1.612 g·cm^-3, μ(MoKα)=1.572 mm^-1, R₁=0.025 4, wR₂=0.070 4. In the complexes 1 and 2, the structures consist of discrete molecules containing six-coordinate tin atom in a distorted octahedron configuration. In crystal of complex 1, molecules are packed in the unit cell in one-dimensional chain structure through a S…S interaction between adjacent molecule. CCDC: 225420, 1; 225421, 2.